Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Vir Biotechnology, Inc.
VIR
Revenue from contracts outside the scope of ASC Topic 606
Revenue from contracts outside the scope of ASC Topic 606 at other companies
The Carlyle Group
CG
-$616.7M
-486%
TPG Inc.
TPG
-$120.02M
-124%
Madison Square Garden Entertainment
MSGE
$9.01M
+6.2%
Intuitive Machines, Inc.
LUNR
$3.1M
—
Columbia Financial, Inc.
CLBK
$4.75M
+242%
General Motors
GM
$4.26B
+0.3%
Segments
By product
See full
Grant revenue
$0
-100%
Other financials
Income statement
See full
Revenue
$238.9M
+19,583%
Gross profit
$238.9M
+19,763%
Operating income
$73.5M
+162%
Net income
$80.1M
+172%
EPS (diluted)
$0.47
+159%
Balance sheet
See full
Cash & equivalents
$287.6M
-6.1%
Total debt
$93.3M
-8.8%
Total equity
$982.5M
+3.7%
Total assets
$1.2B
+1.9%
Cash flow
See full
Operating cash flow
-$132.4M
-69.5%
CapEx
$32.0K
-98.7%
Free cash flow
-$132.8M
-66.5%
Valuation
See full
Market cap
$1.48B
+111%
Enterprise value
$1.29B
+159%
P/S
4.9×
-32.1×
Profitability
See full
Gross margin
96.1%
-2.7pp
Operating margin
-92.4%
-45.5pp
Net margin
-83%
-40.9pp
FCF margin
-686.5%
-273pp
Returns & leverage
See full
Return on equity
-26.1%
-7.9pp
Debt / equity
0.1×
0.0×
Current ratio
6×
-1.0×
Watchlist
Screener
Filings
Earnings
Charts